Related Experiment Video
Updated: Jun 3, 2026

Spatial and Temporal Control of T Cell Activation Using a Photoactivatable Agonist
Published on: April 25, 2018
Modular Vaccine Robots for Spatiotemporal Programming of the CD4+ T Cell-Myeloid Cell Axis
Yu Zhang1,2, Tingting Cui1,2, Huisi Zhao1,2
1Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, P. R. China.
This study introduces a modular vaccine robot that uses magnetic guidance to coordinate immune cells for tumor killing. This novel approach enhances anti-tumor responses by orchestrating CD4+ T cells and myeloid cells.
Area of Science:
- Biomedical Engineering
- Immunology
- Nanotechnology
Background:
- Tumor immunity relies on complex interactions between various immune cells.
- Current cancer vaccines often lack precise control over immune cell coordination.
- Spatiotemporal orchestration of immune responses is crucial for effective anti-tumor activity.
Purpose of the Study:
- To develop a magnetically driven modular Janus vaccine robot (MVR) for spatiotemporal coordination of CD4+ T cell-myeloid cell-mediated tumor killing.
- To investigate the MVR's ability to disrupt tumor cells, release antigens, and guide immune responses.
- To evaluate the MVR's potential to enhance CD4+ T cell activation and myeloid cell differentiation for improved anti-tumor immunity.
Main Methods:
- Fabrication of a modular Janus vaccine robot with orthogonally functional domains.
- Assembly of magnetic nanoparticles (oleic acid-modified CoFe2O4) and aptamers onto the robot's surface.
- Utilizing magnetic fields for MVR guidance and immune cell engagement.
- In vitro and in vivo experiments to assess immune response and tumor suppression.
Main Results:
- MVRs successfully adhered to cell membranes and facilitated antigen release and capture.
- Magnetic guidance directed MVRs to tumor margins, enhancing CD4+ T cell-APC interactions.
- MVRs triggered a feedforward loop, activating CD4+ T cells and differentiating myeloid cells into effector APCs.
- Demonstrated spatially organized, multi-effector immune responses leading to suppression of primary and distal tumors.
Conclusions:
- The developed MVR presents a novel vaccine strategy for spatiotemporal orchestration of the CD4+ T cell-myeloid cell immune loop.
- This approach improves local immune activation and establishes a self-amplifying anti-tumor immune response.
- MVRs show significant potential for enhancing cancer immunotherapy by precisely controlling immune cell interactions.
Related Concept Videos
Cell-mediated Immune Responses
Cells of the Adaptive Immune Response
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

